Humanigen Inc (HGENQ)

[cowtown jay]

This isn't about lenz...yet.

"As the omicron variant threatens to wipe out monoclonal antibodies, the U.S. is saving up one that will still work

Carolyn Y. Johnson
Fri, December 17, 2021, 12:37 AM"

Cameron, do you want to contact her at the Washington Post? She is somewhat misinformed. She writes as follows.

"With the omicron variant of the coronavirus poised to thwart most covid-19 treatments, U.S. public health officials are stockpiling the one monoclonal antibody that remains effective so that it can be deployed when the variant becomes more prevalent...

The decision to pause every-other-week shipments to states of the treatment, sotrovimab, shortly after Thanksgiving is part of a broader strategy to marshal the most effective tools to combat omicron, according to David Kessler, chief scientific officer of the White House covid-19 response team...

At Houston Methodist, omicron grew from 13% of cases to more than 30% in four days. In New York, the percent of positive tests doubled in three days - a key sign of accelerating spread...

When omicron becomes dominant, it is expected to wipe out or weaken much of the covid-19 medicine cabinet, putting the focus on sotrovimab, which is an intravenous infusion from Vir Biotechnology and GlaxoSmithKline. Laboratory studies have shown that the treatment will hold up against the new variant. Antiviral pills that have yet to be authorized are also expected to help fill in the gaps..."

https://www.yahoo.com/news/omicron-variant-threatens-wipe-monoclonal-063758773.html